{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:58:01Z","timestamp":1773230281983,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2082200","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:29:24Z","timestamp":1653474564000},"page":"755-761","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8479-2775","authenticated-orcid":false,"given":"Sepehr","family":"Farahbakhshian","sequence":"first","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Lexington, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-4078","authenticated-orcid":false,"given":"Timothy J.","family":"Inocencio","sequence":"additional","affiliation":[{"name":"OPEN Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-4041","authenticated-orcid":false,"given":"Gregory","family":"Poorman","sequence":"additional","affiliation":[{"name":"OPEN Health, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-9121","authenticated-orcid":false,"given":"Ekaterina","family":"Wright","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Lexington, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9689-6475","authenticated-orcid":false,"given":"Ravi Ramesh","family":"Pathak","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Lexington, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-4576","authenticated-orcid":false,"given":"Michael","family":"Bullano","sequence":"additional","affiliation":[{"name":"Takeda Pharmaceutical Company Limited, Lexington, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.07.004"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1240391"},{"key":"e_1_3_4_4_1","volume-title":"Williams hematology","author":"Zimran A","year":"2016","unstructured":"Zimran A, Elstein D. Gaucher disease and related lysosomal storage diseases. In: Kaushansky K, Lichtman M, Prchal J, editors. Williams hematology. 9th ed. New York (NY): McGraw-Hill; 2016.","edition":"9"},{"issue":"4","key":"e_1_3_4_5_1","first-page":"855","article-title":"High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews","volume":"49","author":"Zimran A","year":"1991","unstructured":"Zimran A, Gelbart T, Westwood B, et\u00a0al. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet. 1991;49(4):855\u2013859.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.12.009"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147699"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01150-6"},{"issue":"1","key":"e_1_3_4_9_1","first-page":"82","article-title":"Management of Gaucher disease: enzyme replacement therapy","volume":"12","author":"Zimran A","year":"2014","unstructured":"Zimran A, Elstein D. Management of Gaucher disease: enzyme replacement therapy. Pediatr Endocrinol Rev. 2014;12(Suppl 1):82\u201387.","journal-title":"Pediatr Endocrinol Rev"},{"key":"e_1_3_4_10_1","unstructured":"CEREZYME [Prescribing information] [cited 2021 Jan 25]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/20367s066lbl.pdf"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.07.009"},{"key":"e_1_3_4_12_1","unstructured":"VPRIV [Prescribing information] [cited 2021 Jan 25]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/022575lbl.pdf"},{"key":"e_1_3_4_13_1","unstructured":"ELELYSO [Prescribing information] [cited 2021 Jan 25]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/022458lbl.pdf"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.10.007"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.10.005"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0426-8"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.2291"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.10.014"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.10.1002"},{"issue":"122","key":"e_1_3_4_20_1","first-page":"1","article-title":"Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999\u20132000 through 2015\u20132016","author":"Fryar CD","year":"2018","unstructured":"Fryar CD, Kruszon-Moran D, Gu Q, et\u00a0al. Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999\u20132000 through 2015\u20132016. Natl Health Stat Report. 2018;(122):1\u201316.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_4_21_1","unstructured":"Academy of Managed Care Pharmacy (AMCP). Managed care glossary 2022 [cited 2022 May 3]. Available from: https:\/\/www.amcp.org\/about\/managed-care-pharmacy-101\/managed-care-glossary"},{"key":"e_1_3_4_22_1","unstructured":"Academy of Managed Care Pharmacy (AMCP). AMCP guide to pharmaceutical payment methods; Executive summary version 3.0 2013 [cited 2022 May 4]. Available from: https:\/\/www.amcp.org\/sites\/default\/files\/2019-03\/MM%20edits-Executive_Summary%20%28final-mar27%29_MB.pdf"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15402"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.10.008"},{"key":"e_1_3_4_25_1","unstructured":"European Medicines Agency. Gaucher disease: a strategic collaborative approach from EMA and FDA. London United Kingdom; 2014 [cited 2021 Sep 29]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/gaucher-disease-strategic-collaborative-approach-european-medicines-agency-food-drug-administration_en.pdf"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168135"}],"updated-by":[{"DOI":"10.1080\/13696998.2023.2197812","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000}},{"DOI":"10.1080\/13696998.2023.2197785","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000}}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2082200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:24:27Z","timestamp":1729164267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2082200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2082200"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2082200","relation":{"addendum":[{"id-type":"doi","id":"10.1080\/13696998.2023.2197812","asserted-by":"object"},{"id-type":"doi","id":"10.1080\/13696998.2023.2197785","asserted-by":"object"}]},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}